Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 study of serplulimab with the bevacizumab biosimi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma
0
Authors
Zhenggang Ren
33 more
Zhenggang Ren
•
Guoliang Shao
31 more
•
Guohua Yu
Published
January 3, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Immunology Immunotherapy
Topics
Medicine
Cancer Oncology
Internal Medicine
Hepatology
Cancer Research
Show all topics
DOI
10.1007/s00262-024-03917-w
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Immunology Immunotherapy
Topics
Medicine
Cancer Oncology
Internal Medicine
Hepatology
Cancer Research
Show all topics
DOI
10.1007/s00262-024-03917-w
License
CC-BY-NC-ND
Other Formats
PDF
